Robotically Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF) Outcomes in the Aging Hispanic Population: A Retrospective Cohort Study

Minimally invasive techniques for lumbar spinal fusions have evolved significantly to treat lumbar spinal stenosis, degenerative spondylolisthesis, and many other complex conditions. This study evaluates the clinical outcomes of patients aged 65 and older who underwent minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) with robotic assistance. In this single-surgeon single-institution retrospective cohort study, 72 patients aged 65 and older who underwent MIS-TLIF from 2018 to 2021 were analyzed. Patients had diagnoses of lumbar spinal stenosis, with or without degenerative spondylolisthesis. Clinical outcomes were assessed using the Oswestry Disability Index (ODI) and Visual Analogue Scale (VAS) for back and lower extremities at baseline, and 6, 9, or 12 months postoperatively. The data was analyzed, and outcomes were compared using paired t-tests. Significant improvements in disability were observed postoperatively, with mean ODI scores decreasing from 46.4% to 9.3% (95% CI: -41.2, -33.1). In terms of pain intensity, mean VAS scores for back pain decreased from 8.0 to 3.5 (95% CI: -5.1, -3.9) and leg pain scores also decreased from 8.2 to 2.9 (95% CI: -5.9, -4.6). These changes indicate substantial clinical improvements (p < 0.001). This study substantiates the efficacy of MIS-TLIF in significantly improving pain relief and functional mobility among seniors with lumbar conditions. The substantial reductions in ODI and VAS scores highlight its clinical benefits potential to set a new standard of care. By offering a robotically assisted, minimally invasive alternative, this approach aligns with contemporary healthcare objectives of enhancing patient recovery while minimizing procedural risks and costs.